2018
Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts
Wallach JD, Ross JS. Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts. JAMA 2018, 319: 776-778. PMID: 29486013, DOI: 10.1001/jama.2017.21897.Commentaries, Editorials and LettersAminesCyclohexanecarboxylic AcidsGabapentinGamma-Aminobutyric AcidHumansOff-Label UseProduct Surveillance, Postmarketing
2011
Study of Neurontin: Titrate to Effect, Profile of Safety (STEPS) Trial: A Narrative Account of a Gabapentin Seeding Trial
Krumholz SD, Egilman DS, Ross JS. Study of Neurontin: Titrate to Effect, Profile of Safety (STEPS) Trial: A Narrative Account of a Gabapentin Seeding Trial. JAMA Internal Medicine 2011, 171: 1100-1107. PMID: 21709111, PMCID: PMC3319750, DOI: 10.1001/archinternmed.2011.241.Peer-Reviewed Original ResearchMeSH KeywordsAminesClinical Trials as TopicConflict of InterestCyclohexanecarboxylic AcidsFemaleGabapentinGamma-Aminobutyric AcidHumansMaleMarketing